Clinical trials
Pain trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 7 |
| Not yet recruiting | 4 |
| Unknown status | 3 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Hong Kong | 9 |
| The Hong Kong Polytechnic University | 5 |
| Chinese University of Hong Kong | 4 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| KeyBioscience AG | 1 |
| Levicept | 1 |
| Pacira Pharmaceuticals, Inc | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Prince of Wales Hospital, Shatin, Hong Kong | 1 |
| Queen Elizabeth Hospital, Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pain | 28 |
| Osteoarthritis, Knee | 8 |
| Osteoarthritis | 5 |
| Anxiety Disorders | 2 |
| Arthritis | 2 |
| Pancreatic Neoplasms | 2 |
| Acute Pain | 1 |
| Agnosia | 1 |
| Cancer Pain | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.